The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.
Presented by Molekule Consulting
• An introduction to EU regulatory pathways and differences to US pathways
• How do we benchmark and make assumptions about EU regulatory timelines?
• Case studies: Examples from past EU approvals
Presented by Lifescience Dynamics
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
· Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
· Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
· Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.
Presented by INOVIS
Strategic workshops are powerful tools for your teams to turn insights into actions and build a winning strategy. Through these workshops, you will get a better understanding of your competitive landscape, evaluate your current strategies, assumptions, and resources, and create new strategies & tactics to help you stay ahead of the competition.
Presented by Atacana Group
Presented by Novartis and STADA
• Leadership
• HR Organization (hybrid working)
• New performance management approach
• New Talent management approach
Presented by Organon
It is an ongoing rollercoaster that challenges governments, nonprofits, and corporate environments. However, there is always an opportunity to thrive in uncertain times by leveraging key insights into utilizing intelligence about the future to anticipate change, understanding the various types of emergence, and avoiding disruption by imagining and building new global scenarios where humans collaborate with AI to understand emerging issues.
Presented by FFWD
However, staying on top of competitive intelligence requires an investment which grows over time. Therefore, it is imperative that an organization sees the value of CI. The Molekule team will provide an overview of how to demonstrate the value of CI by empowering your organization with the takeaways and tactics they need to improve decision-making and execution.
Presented by Molekule Consulting
• Advance your understanding of core regulatory routes, timelines and strategies
• Understand core Gx/biosimilar product development and entry strategies
• Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches
Presented by INOVIS
• Understand how competitors perceive and prioritize key access challenges and their approaches to address them
• Identify GTM activities and strategies that address healthcare systems’ needs and how they are implemented throughout the development and launch of the product
• Assess how success is measured and benchmark by competitors, payers, patients and prescribers
Presented by Lifescience Dynamics
Case studies will be discussed as well as practical implementation of such department, and how it fuels the strategic decision-making at C-suite level or contributes to the dissemination of strategic CI mindset/methodology/tools across the different functions.
Presented by Servier
From the innovators and disruptors, to socio-geo-political aspects, and looking economic uncertainty, we will apply a comprehensive lens to this year’s challenges and potential implications, in order that global CI practitioners remain agile and poised to navigate the dynamics of 2023 and beyond.
Presented by Fletcher
Clinical trials have followed the ‘cave-(wo)man’ test since their inception. Patient takes drug and is compared to patient who doesn’t take drug. However, the gains for this process for new medicine development is diminishing. AI is revolutionising supply chains across industries, and clinical trials are no exception. Join us in Rome to hear how AI will enable faster, safer, and significantly less expensive clinical trials. Discover what the future may lie ahead for clinical trials in silico, learn what is an N=1 trial and how this paves the way for the future of personalised medicine.
Presented by Dig Worldwide
No longer can competitor, market and stakeholder intelligence be delivered on an ad hoc basis in a format that is difficult to decipher; decision-makers require dynamic, targeted, high-impact insight that provides clarity and empowers them to act in a timely manner.
Presented by Prescient
Presented by Novartis
Presented by Alentis Therapeutics
Presented by Chiesi Farmaceutici S.p.A.
• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)
Presented by SOTIO, a.s.
Presented by STADA
Presented by Bristol Myers Squibb
While market research is squarely focused on the “customers” piece of the equation, competitive intelligence provides crucial insight into the way the market shifts as a result of competitor activity. Through this talk, we explain, with the help of some examples, when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.
Presented by Lifescience Dynamics
Presented by Novartis and STADA
The traditional CI model of gathering intelligence and generating insights is not enough. Developing, launching and growing blockbuster brands require a well defined strategic decision making process.
In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, determine risks and opportunities, identify the key success factors, and create an action plan to execute within your winning strategy.
The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, the latest management thinking from Harvard Business School, and years of cross-functional experience within Pharma and at Atacana.
We look forward to seeing you there!
Presented by Atacana Group
Presented by FENIX and CSL Seqirus
• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2022
Presented by Larvol
Presented by Deallus
Presented by GlaxoSmithKline
Presented by Novartis
Presented by Alentis Therapeutics
• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)
Presented by SOTIO, a.s.
Presented by Bristol Myers Squibb and Menarini
Presented by Novartis
In this talk, we will explore the use of neuromarketing techniques in the medical industry and how they can help us understand the unconscious emotions that influence medical decision making. We will present a series of case studies that reveal the emotional components driving medical decision making, and explore how this knowledge can be used to improve marketing strategies and communication in the medical industry.
Moreover, we will discuss the challenges of implementing neuromarketing techniques in the medical industry, including ethical considerations and the need for specialized training. However, the potential benefits of using these techniques to understand the unconscious emotions of patients and physicians far outweigh these challenges.
By the end of this talk, attendees will have a greater understanding of how neuromarketing techniques can be used to understand unconscious emotions in medical decision making. They will also gain insights into how to develop more effective marketing strategies and communication that appeal to the emotional and intuitive responses of both physicians and patients, ultimately leading to more successful engagement and increased sales.
Overall, this talk will provide valuable insights into the power of neuromarketing techniques to improve marketing and communication in the medical industry, and how understanding the unconscious emotions of patients and physicians is key to success in this field.
Presented by University of Amsterdam
Presented by Novartis and STADA